Dow Jones

39,411.21

0.67%

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

RXST

RxSight (RXST)

RxSight Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:RXST

1 2 3 4 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
17/06/2024	17:45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RXST	RxSight Inc
14/06/2024	15:07	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:RXST	RxSight Inc
06/06/2024	15:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RXST	RxSight Inc
05/06/2024	15:05	GlobeNewswire Inc.	RxSight, Inc. To Participate in the Truist Securities Medtech Conference	NASDAQ:RXST	RxSight Inc
16/05/2024	15:30	Edgar (US Regulatory)	Form SD - Specialized disclosure report	NASDAQ:RXST	RxSight Inc
13/05/2024	15:05	GlobeNewswire Inc.	RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares	NASDAQ:RXST	RxSight Inc
09/05/2024	15:59	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:RXST	RxSight Inc
08/05/2024	20:15	GlobeNewswire Inc.	RxSight, Inc. Announces Pricing of Public Offering of Common Stock	NASDAQ:RXST	RxSight Inc
08/05/2024	15:05	GlobeNewswire Inc.	RxSight, Inc. Announces Proposed Public Offering of Common Stock	NASDAQ:RXST	RxSight Inc
08/05/2024	15:01	Edgar (US Regulatory)	Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers	NASDAQ:RXST	RxSight Inc
06/05/2024	15:15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:RXST	RxSight Inc
06/05/2024	15:05	GlobeNewswire Inc.	RxSight, Inc. Reports First Quarter 2024 Financial Results	NASDAQ:RXST	RxSight Inc
01/05/2024	15:05	GlobeNewswire Inc.	RxSight, Inc. to Present at the Bank of America Healthcare Conference	NASDAQ:RXST	RxSight Inc
22/04/2024	15:05	GlobeNewswire Inc.	RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024	NASDAQ:RXST	RxSight Inc
04/04/2024	15:05	GlobeNewswire Inc.	RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting	NASDAQ:RXST	RxSight Inc
27/03/2024	15:05	GlobeNewswire Inc.	RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:RXST	RxSight Inc
29/02/2024	18:05	GlobeNewswire Inc.	RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference	NASDAQ:RXST	RxSight Inc
28/02/2024	15:05	GlobeNewswire Inc.	RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:RXST	RxSight Inc
14/02/2024	16:01	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:RXST	RxSight Inc
14/02/2024	15:05	GlobeNewswire Inc.	RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024	NASDAQ:RXST	RxSight Inc
29/01/2024	16:25	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:RXST	RxSight Inc
07/01/2024	09:00	GlobeNewswire Inc.	RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance	NASDAQ:RXST	RxSight Inc
27/12/2023	15:05	GlobeNewswire Inc.	RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference	NASDAQ:RXST	RxSight Inc
09/11/2023	15:05	GlobeNewswire Inc.	RxSight, Inc. Reports Third Quarter 2023 Financial Results	NASDAQ:RXST	RxSight Inc
02/11/2023	08:00	GlobeNewswire Inc.	RxSight, Inc. Educational and Product Announcements for AAO 2023	NASDAQ:RXST	RxSight Inc
26/10/2023	15:05	GlobeNewswire Inc.	RxSight, Inc. to Report Third Quarter Financial Results on November 9, 2023	NASDAQ:RXST	RxSight Inc
12/09/2023	15:30	Edgar (US Regulatory)	Form 144/A - Report of proposed sale of securities: [Amend]	NASDAQ:RXST	RxSight Inc
23/08/2023	15:05	GlobeNewswire Inc.	RxSight, Inc. to Present at the Wells Fargo Healthcare Conference	NASDAQ:RXST	RxSight Inc
18/08/2023	15:18	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:RXST	RxSight Inc
07/08/2023	15:05	GlobeNewswire Inc.	RxSight, Inc. Reports Second Quarter 2023 Financial Results	NASDAQ:RXST	RxSight Inc